Reference numberRR/68/429
TitleLetter from Arthur James Ewins, regarding a paper 'Experimental chemotherapy of typhus Anti-rickettsial action of p-sulphonamidobenzamidine and related compounds' by Christopher Howard Andrewes, Harold King and James Walker
Date20 February 1945
DescriptionSectional Committee: Physiology

Still feels his comments on the paper are justified, but were mostly suggestions to be taken forward for future publications, as applying them to the current paper would be time consuming. Has no objection to publication of the paper in its present form. Still feels the detail of the experimental part could be condensed.

Note by Archibald Vivian Hill requests publication now.

[Published in the 'Proceedings of the Royal Society of London']

No received date.
Physical descriptionLetter on paper
Digital imagesView item on Science in the Making
Access statusOpen
Related materialDOI: 10.1098/rspb.1946.0002 Vol.133 1946
Related records in the catalogueRR/68/425
Fellows associated with this archive
NA2236Ewins; Arthur James (1882 - 1957)1882 - 1957
NA1249Andrewes; Christopher Howard (1896 - 1988)1896 - 1988
NA1027King; Harold (1887 - 1956)1887 - 1956
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView


    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →


    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView